Magneto-Electric Nanoparticles for Targeted Cell Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for targeting cancer cells, viruses, and bacteria are limited by the reliance on ligands or antibodies matching specific cells, inadequate accumulation due to the Enhanced Permeability and Retention (EPR) effect, and lack of effective methods for treating antibiotic-resistant bacteria and viruses.
Innovation Solution
The use of Magneto-Electric Nano-Particles (MENPs) coated with guiding agents that bind specifically to targeted cells or viruses, combined with an external magnetic field to generate an electric field for disruption or killing, enhancing accumulation and specificity through electric gradient forces.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ligands or antibodies are used to target cancer cells, then specificity to cancer cells is improved, but availability of matching ligands or antibodies is limited
Solution Approach 1:
The patent changes the targeting mechanism from biochemical recognition (ligand-antibody binding) to physical field-based recognition (electric gradient forces acting on charged nanoparticles). By controlling the charge parameters of MENPs and applying external magnetic fields to generate electric gradients, the system achieves universal targeting capability across different cancer cell types without being limited by specific ligand availability.
2Quantity of substance
If EPR effect is used to accumulate nanoparticles at cancer site, then passive accumulation is improved, but accumulation amount and density are insufficient for treatment
Solution Approach 1:
The patent applies external magnetic fields before and during nanoparticle administration to pre-position MENPs at the cancer site and maintain their concentration. This preliminary action overcomes the passive and limited EPR effect by actively concentrating nanoparticles to therapeutic densities before treatment initiation.
Solution Approach 2:
The patent replaces the passive physiological EPR effect (mechanical filtration through leaky vasculature) with an active magnetic field-based concentration system. This substitution enables precise control over nanoparticle accumulation density and location, achieving therapeutic concentrations that EPR alone cannot provide.
3Ease of operation
If point contact electrodes are used for electrical stimulation, then localized stimulation is achieved, but uniform stimulation at cellular level cannot be achieved
Solution Approach 1:
The patent segments the stimulation field into multiple independent magnetic field sources that can be individually controlled. By using arrays of magnets or electromagnets positioned around the treatment area, the system creates a distributed pattern of electric gradients that collectively provide uniform cellular-level stimulation across the entire cancer site, eliminating the non-uniformity caused by single point electrodes.
4Reliability
If conventional methods are used to kill bacteria or viruses, then antibiotic treatment is effective, but antibiotic-resistant bacteria cannot be treated
Solution Approach 1:
The patent replaces biochemical antibiotic mechanisms with physical field-based killing mechanisms. By using magnetic fields to generate intense localized electric gradients that disrupt bacterial and viral structures, the system achieves killing effectiveness against antibiotic-resistant pathogens without relying on biochemical pathways that resistance can develop.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively targets and kills cancer cells, viruses, and bacteria by increasing the negative charge of MENPs, allowing for precise accumulation and electric field-induced disruption, improving treatment efficacy while minimizing harm to normal cells.
Implementation Method 1
applying a magnetic field to the GAC-MENPs to generate an electric field for disrupting or killing the targeted bacteria or viruses
Implementation Method 2
binding the targeted bacteria or viruses with the GAC-MENPs, and applying a magnetic field to the GAC-MENPs
Data Source
AI summary
This invention presents methods for targeting and killing types of cells or organisms using Magneto-Electric Nano-Particles under the control of an external magnetic field. A method was also presented for using Magneto-Electric Nano-Particles to stimulate or rejuvenate cells under an external magnetic field.


